Australia Retinal Vein Occlusion Treatment Market Size & Outlook
Australia retinal vein occlusion treatment market, 2018-2030 (US$M)
Related Markets
Australia retinal vein occlusion treatment market highlights
- The Australia retinal vein occlusion treatment market generated a revenue of USD 48.5 million in 2022 and is expected to reach USD 92.8 million by 2030.
- The Australia market is expected to grow at a CAGR of 8.5% from 2023 to 2030.
- In terms of segment, central retinal vein occlusion (crvo) was the largest revenue generating disease type in 2022.
- Branch Retinal Vein Occlusion (BRVO) is the most lucrative disease type segment registering the fastest growth during the forecast period.
Retinal vein occlusion treatment market data book summary
| Market revenue in 2022 | USD 48.5 million |
| Market revenue in 2030 | USD 92.8 million |
| Growth rate | 8.5% (CAGR from 2022 to 2030) |
| Largest segment | Central retinal vein occlusion (crvo) |
| Fastest growing segment | Branch Retinal Vein Occlusion (BRVO) |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO) |
| Key market players worldwide | AbbVie Inc, Roche Holding AG, Regeneron Pharmaceuticals Inc, Taiwan Liposome, Alcon Inc, CalciMedica Inc Ordinary Shares, Outlook Therapeutics Inc, Kodiak Sciences Inc, Chugai Pharmaceutical Co Ltd, Pfizer Inc |
Other key industry trends
- In terms of revenue, Australia accounted for 2.0% of the global retinal vein occlusion treatment market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China retinal vein occlusion treatment market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 180.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Retinal Vein Occlusion Treatment Market Scope
Retinal Vein Occlusion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia retinal vein occlusion treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to retinal vein occlusion treatment market will help companies and investors design strategic landscapes.
Central retinal vein occlusion (crvo) was the largest segment with a revenue share of 69.28% in 2022. Horizon Databook has segmented the Australia retinal vein occlusion treatment market based on central retinal vein occlusion (crvo), branch retinal vein occlusion (brvo) covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Australia retinal vein occlusion treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia retinal vein occlusion treatment market databook
-
Our clientele includes a mix of retinal vein occlusion treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia retinal vein occlusion treatment market , including forecasts for subscribers. This country databook contains high-level insights into Australia retinal vein occlusion treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia retinal vein occlusion treatment market report size, by disease type, 2018-2030 (US$M)
Australia Retinal Vein Occlusion Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
